Consulting firm.
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | THERMO FISHER SCIENTIFIC INC |
1st Quarter (Jan 1 - Mar 31) AMENDED |
$21,000 | — | |
| 2026 | FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) SOCIETY |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | CELLTRION USA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | NCATS ALLIANCE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | THE PEGGY LILLIS FOUNDATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | GLOBAL DOWN SYNDROME FOUNDATION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2026 | THERMO FISHER SCIENTIFIC INC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$21,000 | — | |
| 2026 | MYOTONIC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | — | |
| 2025 | NCATS ALLIANCE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | — | |
| 2025 | THE PEGGY LILLIS FOUNDATION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| THERMO FISHER SCIENTIFIC INC | 28 | $1,019,000 |
| MYOTONIC | 27 | $30,000 |
| GLOBAL DOWN SYNDROME FOUNDATION | 25 | $5,000 |
| MYRIAD GENETICS, INC. | 21 | $590,000 |
| THE PEGGY LILLIS FOUNDATION | 18 | — |
| PEAR THERAPEUTICS | 16 | $510,000 |
| NCATS ALLIANCE | 10 | — |
| CELLTRION USA, INC. | 7 | — |
| FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) SOCIETY | 6 | — |
| BOEHRINGER INGELHEIM USA CORPORATION | 5 | $60,000 |
| LUMINOPIA, INC. | 5 | — |
| CLICK THERAPEUTICS, INC. | 5 | — |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | 4 | $40,000 |
| FAEGRE BAKER DANIELS CONSULTING (ON BEHALF OF GLOBAL DOWN SYNDROME FOUNDATION) | 4 | $32,000 |
| ATA ACTION | 4 | $20,000 |
| MINDMAZE INC. | 4 | — |
| DIGITAL THERAPEUTICS ALLIANCE | 3 | — |
| Name | Disclosed Prior Position |
|---|---|
| JOHN KEVIN BRENNAN | Rep. Rosa DeLauro, Chief of Staff |